Why Is Larimar Therapeutics Stock Trading Lower On Monday?
On Monday, Larimar Therapeutics, Inc. (NASDAQ:LRMR) released initial data from the ongoing long-term OLE study evaluating daily subcutaneous injections of 25 mg of nomlabofusp self-administered or adm
ICR Capital CEO J.D. Moriarty, Live at Nasdaq MarketSite
IPO Edge hosted a fireside chat on Dec. 10 at Nasdaq MarketSite with J.D. Moriarty, Chief Executive Officer of ICR Capital. The in-person interview was joined by Editor-in-Chief John Jannarone and the
Schizophrenia market expected to reach $17bn across 7MM by 2031
Bristol Myers Squibb’s Cobenfy is the first treatment in seven decades that does not modulate dopaminergic or serotonergic transmission.
Netflix Stock Receives Big Price Target Raise on Live Events
Oppenheimer boosted Netflix's price target, pointing to the benefits of the biggest streaming service's live events.
Analysts revamp Ciena stock price target after AI outlook
Here’s what could be next for the AI network provider.
This Baltimore parking lot attendant built a $500K stock portfolio — even though he never made more than $12/hour
He has a very simple superpower.
Honeywell Stock Rises as It Considers Aerospace Spinoff
Honeywell's latest update on its ongoing portfolio review said the company was considering spinning off its aerospace business.
Palantir Stock Retreats, MicroStrategy Rises on News of Nasdaq 100 Addition
Palantir Technologies, MicroStrategy, and Axon Enterprise are set to join the Nasdaq 100 Index on Monday, Dec. 23, replacing Super Micro Computer, Moderna, and Illumina.
Tesla Stock Hits New All-Time High as Wedbush Boosts Price Target Again
Wedbush again raised its price target on Tesla stock on expectations the new Trump administration will give the EV maker's self-driving and artificial intelligence efforts a boost.
Trillion-dollar companies: 10 most valuable mega-cap stocks
These are the largest publicly traded companies and members of the trillion-dollar club.